The accumulation of senescent cells is increasingly recognized as a hallmark of biological aging, linked to various chronic medical conditions. This study presents a novel approach to measuring cellular senescence burden through a deep-learning derived biomarker known as the senescence-associated secretory phenotype (SASP) Score.
Researchers developed and validated the SASP Score by integrating large-scale population proteomics data with a semi-supervised deep learning framework. The process involved several key steps:
- Selection of SASP Proteins: Biologically curated SASP proteins were selected to represent the cellular senescence burden.
- Guided Autoencoder with Transformer (GAET) Model: This model was developed using data from the UK Biobank Pharma Proteomics Project (UKB-PPP).
- Evaluation and Validation: The model underwent internal evaluation and association analyses within the UK Biobank, followed by external validation in an independent randomized clinical trial cohort.
The findings indicate that the deep learning-based SASP Score is a strong, independent predictor of mortality risk and the onset of serious chronic medical conditions, including dementia, chronic obstructive pulmonary disease (COPD), myocardial infarction, and stroke. Notably, in an independent cohort, multimodal exercise was shown to significantly alter the trajectory of the SASP Score over an 18-month period.
This research highlights the potential of the SASP Score as a biomarker for systemic cellular senescence burden, offering a valuable tool for aging research and the evaluation of interventions guided by geroscience principles. The statistical approach employed in this study enhances interpretability and cross-platform utility, which could be beneficial for future studies in this field.
What this study does not show
While the study identifies the SASP Score as a predictor of mortality and chronic conditions, it does not establish a direct causal relationship between the SASP Score and health outcomes.
Evidence scorecard
- Analytic validity: established
- Clinical validity: partial
- Clinical utility: partial
The evidence is based on primary research involving human subjects.